BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 32764925)

  • 21. The preliminary study of immune superparamagnetic iron oxide nanoparticles for the detection of lung cancer in magnetic resonance imaging.
    Wan X; Song Y; Song N; Li J; Yang L; Li Y; Tan H
    Carbohydr Res; 2016 Jan; 419():33-40. PubMed ID: 26649917
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Curcumin-conjugated magnetic nanoparticles for detecting amyloid plaques in Alzheimer's disease mice using magnetic resonance imaging (MRI).
    Cheng KK; Chan PS; Fan S; Kwan SM; Yeung KL; Wáng YX; Chow AH; Wu EX; Baum L
    Biomaterials; 2015 Mar; 44():155-72. PubMed ID: 25617135
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Aβ-oligomer uptake and the resulting inflammatory response in adult human astrocytes are precluded by an anti-Aβ single chain variable fragment in combination with an apoE mimetic peptide.
    Montoliu-Gaya L; Mulder SD; Herrebout MAC; Baayen JC; Villegas S; Veerhuis R
    Mol Cell Neurosci; 2018 Jun; 89():49-59. PubMed ID: 29625180
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of PEGylated superparamagnetic iron oxide nanoparticles (SPIONs) under magnetic field on amyloid beta fibrillation process.
    Mirsadeghi S; Shanehsazzadeh S; Atyabi F; Dinarvand R
    Mater Sci Eng C Mater Biol Appl; 2016 Feb; 59():390-397. PubMed ID: 26652388
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sigma ligands as potent inhibitors of Aβ and AβOs in neurons and promising therapeutic agents of Alzheimer's disease.
    Ma WH; Chen AF; Xie XY; Huang YS
    Neuropharmacology; 2021 Jun; 190():108342. PubMed ID: 33045243
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sortilin is required for toxic action of Aβ oligomers (AβOs): extracellular AβOs trigger apoptosis, and intraneuronal AβOs impair degradation pathways.
    Takamura A; Sato Y; Watabe D; Okamoto Y; Nakata T; Kawarabayashi T; Oddo S; Laferla FM; Shoji M; Matsubara E
    Life Sci; 2012 Dec; 91(23-24):1177-86. PubMed ID: 22579764
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Alzheimer's disease: pathophysiology and applications of magnetic nanoparticles as MRI theranostic agents.
    Amiri H; Saeidi K; Borhani P; Manafirad A; Ghavami M; Zerbi V
    ACS Chem Neurosci; 2013 Nov; 4(11):1417-29. PubMed ID: 24024702
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of hematopoietic cell kinase dysregulates microglial function and accelerates early stage Alzheimer's disease-like neuropathology.
    Lim SL; Tran DN; Zumkehr J; Chen C; Ghiaar S; Kieu Z; Villanueva E; Gallup V; Rodriguez-Ortiz CJ; Kitazawa M
    Glia; 2018 Dec; 66(12):2700-2718. PubMed ID: 30277607
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Microglial Aβ receptors in Alzheimer's disease.
    Yu Y; Ye RD
    Cell Mol Neurobiol; 2015 Jan; 35(1):71-83. PubMed ID: 25149075
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characterization of a single-chain variable fragment recognizing a linear epitope of aβ: a biotechnical tool for studies on Alzheimer's disease?
    Dornieden S; Müller-Schiffmann A; Sticht H; Jiang N; Cinar Y; Wördehoff M; Korth C; Funke SA; Willbold D
    PLoS One; 2013; 8(3):e59820. PubMed ID: 23555792
    [TBL] [Abstract][Full Text] [Related]  

  • 31. SPION-enhanced magnetic resonance imaging of Alzheimer's disease plaques in AβPP/PS-1 transgenic mouse brain.
    Sillerud LO; Solberg NO; Chamberlain R; Orlando RA; Heidrich JE; Brown DC; Brady CI; Vander Jagt TA; Garwood M; Vander Jagt DL
    J Alzheimers Dis; 2013; 34(2):349-65. PubMed ID: 23229079
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Amyloid β oligomers (AβOs) in Alzheimer's disease.
    Mroczko B; Groblewska M; Litman-Zawadzka A; Kornhuber J; Lewczuk P
    J Neural Transm (Vienna); 2018 Feb; 125(2):177-191. PubMed ID: 29196815
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Monoclonal antibody-conjugated superparamagnetic iron oxide nanoparticles for imaging of epidermal growth factor receptor-targeted cells and gliomas.
    Mu K; Zhang S; Ai T; Jiang J; Yao Y; Jiang L; Zhou Q; Xiang H; Zhu Y; Yang X; Zhu W
    Mol Imaging; 2015; 14():. PubMed ID: 26044549
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cromolyn Reduces Levels of the Alzheimer's Disease-Associated Amyloid β-Protein by Promoting Microglial Phagocytosis.
    Zhang C; Griciuc A; Hudry E; Wan Y; Quinti L; Ward J; Forte AM; Shen X; Ran C; Elmaleh DR; Tanzi RE
    Sci Rep; 2018 Jan; 8(1):1144. PubMed ID: 29348604
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Preparation of Amyloid Immuno-Nanoparticles as Potential MRI Contrast Agents for Alzheimer's Disease Diagnosis.
    Yin Z; Yul T; Xu Y
    J Nanosci Nanotechnol; 2015 Sep; 15(9):6429-34. PubMed ID: 26716196
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Influence of the physiochemical properties of superparamagnetic iron oxide nanoparticles on amyloid β protein fibrillation in solution.
    Mahmoudi M; Quinlan-Pluck F; Monopoli MP; Sheibani S; Vali H; Dawson KA; Lynch I
    ACS Chem Neurosci; 2013 Mar; 4(3):475-85. PubMed ID: 23509983
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Iodinated oil-loaded, fluorescent mesoporous silica-coated iron oxide nanoparticles for magnetic resonance imaging/computed tomography/fluorescence trimodal imaging.
    Xue S; Wang Y; Wang M; Zhang L; Du X; Gu H; Zhang C
    Int J Nanomedicine; 2014; 9():2527-38. PubMed ID: 24904212
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Co-association of methotrexate and SPIONs into anti-CD64 antibody-conjugated PLGA nanoparticles for theranostic application.
    Moura CC; Segundo MA; Neves Jd; Reis S; Sarmento B
    Int J Nanomedicine; 2014; 9():4911-22. PubMed ID: 25364249
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Theranostic MUC-1 aptamer targeted gold coated superparamagnetic iron oxide nanoparticles for magnetic resonance imaging and photothermal therapy of colon cancer.
    Azhdarzadeh M; Atyabi F; Saei AA; Varnamkhasti BS; Omidi Y; Fateh M; Ghavami M; Shanehsazzadeh S; Dinarvand R
    Colloids Surf B Biointerfaces; 2016 Jul; 143():224-232. PubMed ID: 27015647
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sialic acid (SA)-modified selenium nanoparticles coated with a high blood-brain barrier permeability peptide-B6 peptide for potential use in Alzheimer's disease.
    Yin T; Yang L; Liu Y; Zhou X; Sun J; Liu J
    Acta Biomater; 2015 Oct; 25():172-83. PubMed ID: 26143603
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.